XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net loss $ (41,082) $ (32,213)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation 25,594 29,141
Amortization of intangibles 11,183 11,516
Amortization of operating leases 13,256 12,524
Amortization of deferred financing costs 7,602 7,413
Provision for doubtful accounts 526 333
Provision for inventory obsolescence 1,738 2,320
Stock-based compensation expense 2,946 2,169
Loss on sale of property and equipment 256 292
Loss on revaluation of contingent liability 104 437
Changes in operating assets and liabilities    
Accounts receivable, net 6,724 16,489
Inventories, net 1,710 5,219
Prepaid expenses and other current assets (995) 1,148
Accounts payable and accrued expenses (2,092) 1,058
Income taxes receivable/payable 212 252
Operating lease obligations (13,080) (12,344)
Other assets and liabilities (1,407) (245)
Net cash provided by operating activities 13,195 45,509
Cash flows from investing activities    
Proceeds from sales of property and equipment 585 606
Proceeds from property and equipment casualty losses 0 840
Purchases of property and equipment (14,763) (24,603)
Net cash used in investing activities (14,178) (23,157)
Cash flows from financing activities    
Proceeds from issuance of common stock under ATM program 8,249 0
Proceeds from Units offering, net of discount 0 279,750
Redemption of 2023 Notes 0 (307,339)
Cost of debt issuance 0 (6,290)
Proceeds from ABL Credit Facility 3,000 40,000
Payments on ABL Credit Facility (13,000) (15,000)
Proceeds from short-term debt 5,762 4,733
Payments of short-term debt (5,041) (4,141)
Principle payments on finance leases (49) (217)
Payments of contingent liability (604) (387)
Vesting of restricted stock and stock units 0 (2)
Net cash used in financing activities (1,683) (8,893)
Impact of foreign currency exchange on cash (294) (64)
Net (decrease) increase in cash and cash equivalents (2,960) 13,395
Cash and cash equivalents    
Cash and cash equivalents at beginning of period 30,840 17,445
Cash and cash equivalents at end of period 27,880 30,840
Supplemental disclosures of cash flow information:    
Cash paid for interest 43,939 31,431
Cash paid for income taxes 525 563
Supplemental schedule of non-cash activities:    
Capital expenditures in accounts payable and accrued expenses $ 889 $ 1,107